Transcranial magnetic stimulation (TMS) therapy for autism: an international consensus conference held in conjunction with the international meeting for autism research on May 13th and 14th, 2014.

Lindsay M Oberman,Manuel F Casanova,James T Mccracken,Alexander Rotenberg,Alvaro Pascual-Leone,Peter G Enticott

doi:10.3389/fnhum.2014.01034

Abstract

Transcranial magnetic stimulation (TMS) therapy for autism: an international consensus conference held in conjunction with the international meeting for autism research on May 13th and 14th, 2014.

Highlights

A number of investigators have begun to explore the use of transcranial magnetic stimulation (TMS) as a tool to characterize Autism Spectrum Disorder (ASD) pathophysiology, and to test its therapeutic potential
In an effort to share recent progress in the use of transcranial magnetic stimulation (TMS) in Autism Spectrum Disorder (ASD), promote collaboration across laboratories, and establish consensus on parameters that may be useful for the study of pathophysiology and the potential treatment of ASD, leading experts in the field gathered in Atlanta, GA on May 13th and 14th 2014 for the “Transcranial Magnetic Stimulation (TMS) Therapy for Autism Consensus Conference” organized and supported by the Clearly Present Foundation with additional support from Neuronetics, Inc. and Autism Speaks
Though relatively few patients with ASD have participated in TMS protocols, the frequency and quality of sideeffects shown far approximates that seen in the general population (Oberman et al, 2013)

Summary

Introduction

A number of investigators have begun to explore the use of transcranial magnetic stimulation (TMS) as a tool to characterize ASD pathophysiology, and to test its therapeutic potential. In an effort to share recent progress in the use of TMS in ASD, promote collaboration across laboratories, and establish consensus on parameters that may be useful for the study of pathophysiology and the potential treatment of ASD, leading experts in the field gathered in Atlanta, GA on May 13th and 14th 2014 for the “Transcranial Magnetic Stimulation (TMS) Therapy for Autism Consensus Conference” organized and supported by the Clearly Present Foundation with additional support from Neuronetics, Inc. and Autism Speaks.

Results

Conclusion